Search for content, post, videos

Vakona receives 14 million SEK investment

Vakona has been given a capital injection from five investors to help it develop a new drug to treat acne. “This is a significant investment for us, as now we can continue with our product development," says Gabriella Persson, CEO of Vakona. Three of the investors, Stoaf III SciTech, Partner
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.